Position in ALNY
as of Dec 31, 2025
· filed Jan 29, 2026
Position Value
$5,389,721,058
-$796,125,054 QoQ
Shares Held
13,553,932
-0.1% QoQ
Ownership
10.2%
of shares outstanding
% of Portfolio
0.08%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
24 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 6.635255363535836.ToString("F0")%
None 93.36474463646415.ToString("F0")%
Common Shares in ALNY Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Dec 31, 2025VANGUARD GROUP INC holds $65,710,756,184 across 450 Biotechnology names. ALNY ranks #3 (8.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
24,105,823 | $10,928,615,912 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
9,075,153 | $7,004,838,343 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
This page
|
13,553,932 | $5,389,721,058 | |
| 4 | INSM |
INSMED Inc
|
21,076,344 | $3,668,126,907 | |
| 5 | INCY |
Incyte Corp
|
19,911,434 | $1,966,652,333 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
16,719,886 | $1,331,738,919 | |
| 7 | IONS |
Ionis Pharmaceuticals Inc
|
16,440,459 | $1,300,604,709 | |
| 8 | BBIO |
BridgeBio Pharma, Inc.
|
16,862,691 | $1,289,827,232 |
All Filings in ALNY
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2025-12-31 | $5,389,721,058 | 13,553,932 | Shares | Defined | 2026-01-29 | |
| 2025-09-30 | $6,185,846,112 | 13,565,452 | Shares | Sole | 2025-11-07 | |
| 2025-06-30 | $4,336,064,054 | 13,297,139 | Shares | Sole | 2025-08-11 | |
| 2025-03-31 | $3,525,544,480 | 13,056,605 | Shares | Defined | 2025-05-09 | |
| 2024-12-31 | $2,996,296,117 | 12,733,399 | Shares | Defined | 2025-02-11 | |
| 2024-09-30 | $3,475,030,450 | 12,635,096 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $3,039,390,054 | 12,507,778 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $1,792,542,303 | 11,994,261 | Shares | Defined | 2024-05-10 | |
| 2023-12-31 | $2,286,180,939 | 11,943,895 | Shares | Defined | 2024-03-11 | |
| 2023-09-30 | $2,064,424,768 | 11,656,831 | Shares | Sole | 2023-12-18 | |
| 2023-06-30 | $2,208,284,795 | 11,626,223 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $2,325,348,012 | 11,608,167 | Shares | Sole | 2023-07-14 | |
| 2022-12-31 | $2,734,666,115 | 11,507,116 | Shares | Defined | 2023-02-10 | |
| 2022-09-30 | $2,212,430,127 | 11,053,308 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $1,610,539,580 | 11,042,438 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $1,768,290,922 | 10,829,144 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $1,814,975,904 | 10,702,771 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $2,004,139,224 | 10,614,582 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $1,779,569,084 | 10,497,694 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $1,494,612,063 | 10,585,821 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $1,368,119,323 | 10,526,424 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $1,533,489,191 | 10,532,206 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $1,614,574,360 | 10,901,184 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $1,147,910,871 | 10,545,805 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||